Sift Healthcare

Sift Healthcare addresses a real pain point: revenue loss that begins before billing. Most denial management tools react after the fact, but Sift’s RevProtect predicts underpayments, DRG downgrades, and clinical takeback probabilities as care is being documented. That pre-bill intelligence is rare and valuable. The platform’s depth in clinical data integration is a clear strength. With 329 proprietary MS-DRG playbooks and 10,000+ data points per claim, it’s not a surface-level dashboard. It surfaces the clinical root cause of revenue risk tied to specific documentation patterns, which is actionable for CDI, coding, and UR teams. However, this power comes with scale requirements. Sift targets health systems with significant denial rates and complex payer mixes. Its own materials cite a $0M annual denial reduction opportunity for a representative $1B system — that kind of ROI only makes sense at enterprise scale. Smaller hospitals or clinics likely can’t justify the investment or integration effort. Compared to competitors like Waystar or Cerner’s denial tools, Sift’s differentiating factor is its focus on pre-bill prediction. Where others offer retroactive denial workflows, Sift aims to prevent the denial before it happens. That’s a smarter approach, but it requires tight EHR integration and workflow adoption to succeed. Where it bites: the lack of public pricing and the enterprise-only sales model means most visitors won’t get a number without a demo call. Additionally, if your organization already has a well-optimized revenue cycle with low denial rates, Sift’s value may be marginal. It’s best for those with the scale and complexity to benefit from advanced predictive models — not for those looking for a quick denial recovery fix.